Skip to main navigation Skip to search Skip to main content

Skin-to-skin contact diminishes pain from hepatitis B vaccine injection in healthy full-term neonates

  • Raouth R Kostandy
  • , Gene C. Anderson
  • , Marion Good

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

Purpose: This study was conducted to test the hypothesis that skin-to-skin contact (SSC) would reduce hepatitis B vaccine injection pain in full-term neonates. Design: Randomized controlled trial (RCT ). Sample: Thirty-six mother-neonate dyads were randomly assigned to SSC or control groups. Main Outcomes: Cry time (CT ), behavioral state (BSt), and heart rate (HR ) were measured throughout the 16-minute protocol. HR and BSt were measured every 30 seconds; CT was recorded continuously. Results: SSC neonates cried less compared with controls (23 vs 32 seconds during injection; 16 vs 72 seconds during recovery), reached calmer BSts sooner (M 5 2.8 vs M 5 6.5 time points), and trended toward more rapid HR decrease. SSC as described was safe and effective and merits further testing. © 2013 Springer Publishing Company.
Original languageEnglish
Pages (from-to)274-280
Number of pages7
JournalNeonatal Network
Volume32
Issue number4
DOIs
StatePublished - Jan 1 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this